Antipsychotic treatment among youth in foster care

Pediatrics

Volumn 128, Issue 6, 2011, Pages

  DosReis, Susan ^a   Yoon, Yesel ^b   Rubin, David M ^c   Riddle, Mark A ^b   Noll, Elizabeth ^c   Rothbard, Aileen ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antipsychotic; Children; Foster care; Psychotropic use

Indexed keywords

ANTIDEPRESSANT AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT;

ADOLESCENT; ADOPTION; ADULT; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BIPOLAR DISORDER; CHILD; COMORBIDITY; CONDUCT DISORDER; CONTROLLED STUDY; DEPRESSION; DISABILITY; FEMALE; FOSTER CARE; HEALTH CARE FINANCING; HEALTH PROGRAM; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAID; MEDICAL FEE; MENTAL DISEASE; OPPOSITIONAL DEFIANT DISORDER; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SCHOOL CHILD; SUBSTANCE ABUSE; UNITED STATES;

EID: 83155173346     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-2970     Document Type: Article

References (37)

1. dosReis S, Zito JM, Safer DJ, Soeken KL. Mental health services for youths in foster care and disabled youths. Am J Public Health. 2001;91(7):1094-1099 (Pubitemid 32574834)
2. Raghavan R, Zima BT, Andersen RM, Leibowitz AA, Schuster MA, Landsverk J. Psychotropic medication use in a national probability sample of children in the child welfare system. J Child Adolesc Psychopharmacol. 2005;15(1):97-106 (Pubitemid 40365919)
3. Zima BT, Bussing R, Crecelius GM, Kaufman A, Belin TR. Psychotropic medication treatment patterns among school-aged children in foster care. J Child Adolesc Psychopharmacol. 1999;9(3):135-147 (Pubitemid 29463586)
4. Zito JM, Safer DJ, Zuckerman IH, Gardner JF, Soeken K. Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatr Serv. 2005;56(2):157-163 (Pubitemid 40216770)
5. Breland-Noble AM, Elbogen EB, Farmer EMZ, Wagner HR, Burns BJ. Use of psychotropic medications by youths in therapeutic foster care and group homes. Psychiatr Serv. 2004;55(6):706-708 (Pubitemid 38720864)
6. Zito JM, Safer DJ, Sai D, et al. Psychotropic medication patterns among youth in foster care. Pediatrics. 2008;121(1). Available at: www.pediatrics.org/cgi/content/full/121/1/e157
7. Rubin DM, Feudtner C, Localio R, Mandell DS. State variation in psychotropic medication use by foster care children with autism spectrum disorder. Pediatrics. 2009;124(2). Available at: www.pediatrics.org/cgi/content/ full/124/2/e305
8. Olfson M, Crystal S, Huang C, Gerhard T. Trends in antipsychotic drug use by very young, privately insured children. J Am Acad Child Adolesc Psychiatry. 2010;49(1):13-23
9. Olfson M, Blanco C, Liu L, Moreno C, Laje G. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry. 2006;63(6):679-685 (Pubitemid 43848299)
10. Cooper WO, Arbogast PG, Ding H, Hickson GB, Fuchs DC, Ray WA. Trends in prescribing of antipsychotic medications for US children. Ambul Pediatr. 2006;6(2):79-83 (Pubitemid 43960577)
11. Patel NC, Sanchez RJ, Johnsrud MT, Crismon ML. Trends in antipsychotic use in a Texas Medicaid population of children and adolescents, 1996-2000. J Child Adolesc Psychopharmacol. 2002;12(3):221-229 (Pubitemid 35191348)
12. Domino ME, Swartz MS. Who are the new users of antipsychotic medications? Psychiatr Serv. 2008;59(5):507-514
13. Constantine R, Tandon R. Changing trends in pediatric antipsychotic use in Florida's Medicaid program. Psychiatr Serv. 2008;59(10):1162-1168
14. Kalverdijk LJ, Tobi H, van den Berg PB, et al. Use of antipsychotic drugs among Dutch youths between 1997 and 2005. Psychiatr Serv. 2008;59(5):554-560
15. Correll CU. Multiple antipsychotic use associated with metabolic and cardiovascular adverse events in children and adolescents. Evid Based Ment Health. 2009;12(3):93
16. Crystal S, Olfson M, Huang C, Pincus H, Gerhard T. Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. Health Aff (Millwood). 2009;28(5):w770-w781
17. Centorrino F, Fogarty KV, Sani G, Salvatore P, Cimbolli P, Baldessarini RJ. Antipsychotic drug use: McLean Hospital, 2002. Hum Psychopharmacol. 2005;20(5):355-358 (Pubitemid 41093938)
18. Ganguly R, Kotzan JA, Miller LS, Kennedy K, Martin BC. Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000. J Clin Psychiatry. 2004;65(10):1377-1388
19. Gilmer TP, Dolder CR, Folsom DP, Mastin W, Jeste DV. Antipsychotic polypharmacy trends among Medicaid beneficiaries with schizophrenia in San Diego County, 1999-2004. Psychiatr Serv. 2007;58(7):1007-1010 (Pubitemid 47122882)
20. Lurie N, Popkin M, Dysken M, Moscovice I, Finch M. Accuracy of diagnoses of schizophrenia in Medicaid claims. Hosp Community Psychiatry. 1992;43(1):69-71
21. Walkup JT, Boyer CA, Kellermann SL. Reliability of Medicaid claims files for use in psychiatric diagnoses and service delivery. Adm Policy Ment Health. 2000;27(3):129-139 (Pubitemid 30205260)
22. Lessler JT, Harris BSH. Medicaid as a Source for Postmarketing Surveillance Information, Final Report. Volume I: Technical Report. Research Triangle Park, NC: Research Triangle Institute; 1984
23. Rubin DM, Pati S, Luan X, Alessandrini EA. A sampling bias in identifying children in foster care using Medicaid data. Ambul Pediatr. 2005;5(3):185-190 (Pubitemid 40852134)
24. dosReis S, Zito JM, Buchanan RW, Lehman AF. Antipsychotic dosing and concurrent psychotropic treatments for Medicaid-insured individuals with schizophrenia. Schizophr Bull. 2002;28(4):607-617 (Pubitemid 36569790)
25. Halfon N, Berkowitz G, Klee L. Mental health service utilization by children in foster care in California. Pediatrics. 1992;89(6 pt 2):1238-1244
26. Covell NH, Jackson CT, Evans AC, Essock SM. Antipsychotic prescribing practices in Connecticut's public mental health system: rates of changing medications and prescribing styles. Schizophr Bull. 2002;28(1):17-29 (Pubitemid 34534747)
27. Goren JL, Parks JJ, Ghinassi FA, et al. When is antipsychotic polypharmacy supported by research evidence? Implications for QI. Jt Comm J Qual Patient Saf. 2008;34(10):571-582
28. Burns BJ, Phillips SD, Wagner HR, et al. Mental health need and access to mental health services by youths involved with child welfare: a national survey. J Am Acad Child Adolesc Psychiatry. 2004;43(8):960-970 (Pubitemid 38971717)
29. Raghavan R, Inoue M, Ettner SL, Hamilton BH, Landsverk J. A preliminary analysis of the receipt of mental health services consistent with national standards among children in the child welfare system. Am J Public Health. 2010;100(4):742-749
30. Correll CU, Carlson HE. Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. J Am Acad Child Adolesc Psychiatry. 2006;45(7):771-791 (Pubitemid 43932904)
31. Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA. 2009;28 (16):1765-1773
32. Fedorowicz VJ, Fombonne E. Metabolic side effects of atypical antipsychotics in children: a literature review. J Psychopharmacol. 2005;19(5):533-550 (Pubitemid 41392308)
33. Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;15 (3):225-235
34. Naylor MW, Davidson CV, Ortega-Piron DJ, Bass A, Gutierrez A, Hall A. Psychotropic medication management for youth in state care: consent, oversight, and policy considerations. Child Welfare. 2007;86(5):175-192
35. Zima BT, Bussing R, Crecelius GM, Kaufman A, Belin TR. Psychotropic medication use among children in foster care: Relationship to severe psychiatric disorders. Am J Public Health. 1999;89(11):1732-1735 (Pubitemid 29508223)
36. Essock SM, Covell NH, Leckman-Westin E, et al. Identifying clinically questionable psychotropic prescribing practices for Medicaid recipients in New York state. Psychiatr Serv. 2009;60(12):1595-1602
37. Crismon ML, Argo T. The use of psychotropic medication for children in foster care. Child Welfare. 2009;88(1):71-100